SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 3.07 |
Enterprise Value ($M) | -4.08 |
Book Value ($M) | 5.33 |
Book Value / Share | 1.21 |
Price / Book | 0.58 |
NCAV ($M) | 5.03 |
NCAV / Share | 1.14 |
Price / NCAV | 0.61 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -2.40 |
Return on Assets (ROA) | -1.04 |
Return on Equity (ROE) | -1.31 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.84 |
Current Ratio | 2.84 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 7.89 |
Assets | 8.19 |
Liabilities | 2.86 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -14.86 |
Net Income | -14.44 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -12.19 |
Cash from Investing | 0.00 |
Cash from Financing | 9.58 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Armistice Capital, Llc | 9.99 | 127.08 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
21,392 | 100,278 | 21.33 | |
1,956,244 | 5,357,277 | 36.52 | |
7,080 | 57,014 | 12.42 | |
9,687 | 23,371 | 41.45 | |
(click for more detail) |
Similar Companies | |
---|---|
ORGO – Organogenesis Holdings Inc. | ORMP – Oramed Pharmaceuticals Inc. |
OTLK – Outlook Therapeutics, Inc. | PASG – Passage Bio, Inc. |
PCSA – Processa Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io